Single‑cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer.

Discov Oncol · 2025 · PMC12229426 · PMID 40608205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

2 A), high TMEM71 expression was associated with significantly worse prognosis in multiple tumors, while it showed a favorable trend in some cancer types.

also in 907 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.